{
  "id": "prt_9686f605c001MKEab9Xqd4TpQG",
  "messageID": "msg_9686eaaa9001ncp4X3sxFQYlqi",
  "sessionID": "ses_6a7af0913ffePKeafEVjU8Zw0Y",
  "type": "tool",
  "tool": "read",
  "callID": "toolu_011h6DnnWPxTVcdyKvWNjejb",
  "state": {
    "status": "completed",
    "input": {
      "filePath": "/home/user/project/lib/translations/en.ts"
    },
    "output": "<file>\n00001| import { Translation } from './types'\n00002| \n00003| export const en: Translation = {\n00004|   app: {\n00005|     title: 'InvisibleDx: ME/CFS · Long COVID · POTS',\n00006|     subtitle: 'An educational tool for learning evidence-based criteria for ME/CFS, Long COVID, and POTS. For healthcare education and research purposes only.',\n00007|     tagline: 'Making invisible diseases visible - with evidence, empathy and code.',\n00008|     backToDashboard: 'Back to Dashboard'\n00009|   },\n00010| \n00011|   common: {\n00012|     yes: 'Yes',\n00013|     no: 'No',\n00014|     next: 'Next',\n00015|     previous: 'Previous',\n00016|     continue: 'Continue',\n00017|     complete: 'Complete',\n00018|     cancel: 'Cancel',\n00019|     save: 'Save',\n00020|     download: 'Download',\n00021|     loading: 'Loading',\n00022|     processing: 'Processing',\n00023|     error: 'Error',\n00024|     success: 'Success',\n00025|     retry: 'Retry',\n00026|     close: 'Close',\n00027|     step: 'Step',\n00028|     of: 'of',\n00029|     progress: 'Progress',\n00030|     completing: 'Completing',\n00031|     saving: 'Saving',\n00032|     back: 'Back',\n00033|     goBack: 'Go Back',\n00034|     exit: 'Exit',\n00035|     restart: 'Restart',\n00036|     reset: 'Reset',\n00037|     confirm: 'Confirm',\n00038|     areYouSure: 'Are you sure?',\n00039|     age: 'Age',\n00040|     gender: 'Gender',\n00041|     male: 'Male',\n00042|     female: 'Female',\n00043|     other: 'Other',\n00044|     question: 'Question',\n00045|     minute: 'minute',\n00046|     minutes: 'minutes',\n00047|     bpm: 'bpm',\n00048|     criteria: 'Criteria',\n00049|     met: 'Met',\n00050|     notMet: 'Not Met',\n00051|     high: 'High',\n00052|     medium: 'Medium',\n00053|     low: 'Low',\n00054|     none: 'None',\n00055|     mild: 'Mild',\n00056|     moderate: 'Moderate',\n00057|     severe: 'Severe',\n00058|     confidence: 'Confidence',\n00059|     sensitivity: 'Sensitivity',\n00060|     score: 'Score',\n00061|     results: 'Results',\n00062|     recommendations: 'Recommendations',\n00063|     clinician: 'Clinician',\n00064|     patientId: 'Patient ID',\n00065|     required: 'Required',\n00066|     optional: 'Optional',\n00067|     category: 'Category'\n00068|   },\n00069| \n00070|   dashboard: {\n00071|     smartAssessment: {\n00072|       title: 'Educational Simulation',\n00073|       description: 'Interactive learning workflow with educational documentation examples',\n00074|       autoRouting: 'Auto-routing',\n00075|       soapNotes: 'SOAP notes',\n00076|       icdCodes: 'ICD-10 codes',\n00077|       startNew: 'Start Learning Session'\n00078|     },\n00079|     modules: {\n00080|       quickScreen: {\n00081|         title: 'Initial Screening',\n00082|         description: 'Chief complaint & symptom review (16 questions, ~2 min)'\n00083|       },\n00084|       redFlag: {\n00085|         title: 'Differential Diagnosis',\n00086|         description: 'Rule out alternative diagnoses & red flag symptoms'\n00087|       },\n00088|       standTest: {\n00089|         title: 'Orthostatic Vitals',\n00090|         description: 'Standing test with heart rate monitoring (NASA protocol)'\n00091|       },\n00092|       pemQuest: {\n00093|         title: 'PEM Assessment',\n00094|         description: 'Post-exertional malaise symptom evaluation'\n00095|       },\n00096|       criteriaEngine: {\n00097|         title: 'Diagnostic Criteria',\n00098|         description: 'Apply clinical criteria (CDC, WHO, ESC guidelines)'\n00099|       },\n00100|       subtypeAdvisor: {\n00101|         title: 'Clinical Management',\n00102|         description: 'Condition subtyping & treatment planning examples'\n00103|       }\n00104|     },\n00105|     stats: {\n00106|       diagnosticDelay: '4-5 year avg diagnostic delay',\n00107|       doctorsConsulted: '≥7 doctors typically consulted',\n00108|       sensitivityValidated: '94% sensitivity validated'\n00109|     },\n00110|     algorithm: {\n00111|       title: 'Educational Algorithm',\n00112|       mecfs: {\n00113|         title: 'ME/CFS',\n00114|         criteria: 'CDC/NASEM 2015 + IOM criteria',\n00115|         description: '3 core + 1 PEM symptom cluster'\n00116|       },\n00117|       longCovid: {\n00118|         title: 'Long COVID',\n00119|         criteria: 'WHO + NASEM 2024 criteria',\n00120|         description: '≥3 months post-SARS-CoV-2'\n00121|       },\n00122|       pots: {\n00123|         title: 'POTS',\n00124|         criteria: 'ESC 2018 + AAS/EFAS 2021',\n00125|         description: 'HR↑≥30 bpm within 10 min'\n00126|       }\n00127|     },\n00128|     startAssessment: 'Start Assessment'\n00129|   },\n00130| \n00131|   quickScreen: {\n00132|     title: 'Quick-Screen Assessment',\n00133|     description: '16 questions · ~2 minutes · 92% sensitivity',\n00134|     questions: [\n00135|       'Do you experience severe fatigue that is not relieved by rest?',\n00136|       'Does physical or mental activity make your symptoms worse (Post-Exertional Malaise)?',\n00137|       'Do you have unrefreshing sleep, regardless of duration?',\n00138|       'Do you experience cognitive difficulties (brain fog, memory problems)?',\n00139|       'Do you have palpitations or rapid heart rate, especially when standing?',\n00140|       'Do you experience dizziness or lightheadedness when standing up?',\n00141|       'Have you had COVID-19 or suspected COVID-19 infection?',\n00142|       'Have your symptoms persisted for 3 months or longer?',\n00143|       'Do you experience muscle pain or joint pain without swelling?',\n00144|       'Do you have frequent headaches or changes in headache patterns?',\n00145|       'Do you experience temperature dysregulation (feeling too hot/cold)?',\n00146|       'Do you have gastrointestinal symptoms (nausea, bloating, changes in bowel habits)?',\n00147|       'Do you experience shortness of breath or breathing difficulties?',\n00148|       'Have you noticed decreased exercise tolerance or physical capacity?',\n00149|       'Do you experience sensitivity to light, sound, or touch?',\n00150|       'Have you been unable to maintain your previous level of activity?'\n00151|     ],\n00152|     categories: {\n00153|       core: 'Core',\n00154|       pem: 'PEM',\n00155|       cardiovascular: 'Cardiovascular',\n00156|       orthostatic: 'Orthostatic',\n00157|       history: 'History',\n00158|       duration: 'Duration',\n00159|       pain: 'Pain',\n00160|       neurological: 'Neurological',\n00161|       autonomic: 'Autonomic',\n00162|       gi: 'GI',\n00163|       respiratory: 'Respiratory',\n00164|       functional: 'Functional',\n00165|       sensory: 'Sensory'\n00166|     },\n00167|     results: {\n00168|       complete: 'Screening Complete',\n00169|       riskAssessment: 'Educational simulation - Based on your responses, here\\'s the learning scenario',\n00170|       lowRisk: 'Low Risk for ME/CFS, Long COVID, or POTS',\n00171|       mediumRisk: 'Medium Risk for ME/CFS, Long COVID, or POTS',\n00172|       highRisk: 'High Risk for ME/CFS, Long COVID, or POTS',\n00173|       totalResponses: 'Total positive responses',\n00174|       coreSymptoms: 'Core symptoms present',\n00175|       pemPresent: 'Post-exertional malaise',\n00176|       covidHistory: 'COVID history',\n00177|       chronicSymptoms: 'Chronic symptoms (≥3 months)',\n00178|       nextSteps: 'Next Steps',\n00179|       retake: 'Retake Screening'\n00180|     },\n00181|     nextStepsRecommendations: {\n00182|       high: [\n00183|         'Proceed to Red-flag Checker',\n00184|         'Complete Stand-Test Pro',\n00185|         'Consider PEM-Quest assessment'\n00186|       ],\n00187|       medium: [\n00188|         'Consider Red-flag Checker',\n00189|         'Monitor symptoms closely',\n00190|         'Follow-up in 4-6 weeks'\n00191|       ],\n00192|       low: [\n00193|         'Routine clinical assessment',\n00194|         'Consider other diagnoses',\n00195|         'Reassess if symptoms worsen'\n00196|       ]\n00197|     }\n00198|   },\n00199| \n00200|   redFlag: {\n00201|     title: 'Red-flag Checker',\n00202|     description: 'Identify symptoms requiring urgent evaluation and rule out explanatory diseases',\n00203|     symptoms: {\n00204|       title: 'Red Flag Symptoms',\n00205|       description: 'Check any symptoms present that may require urgent evaluation',\n00206|       list: [\n00207|         'Persistent fever or night sweats',\n00208|         'Unintentional weight loss >10% in 6 months',\n00209|         'Chest pain with exertion or at rest',\n00210|         'Progressive shortness of breath',\n00211|         'New neurological symptoms (weakness, numbness, seizures)',\n00212|         'Abnormal bleeding or bruising',\n00213|         'Enlarged lymph nodes',\n00214|         'Jaundice or yellowing of skin/eyes'\n00215|       ]\n00216|     },\n00217|     urgentCategories: [\n00218|       'Infectious/Inflammatory',\n00219|       'Malignancy/Metabolic', \n00220|       'Cardiovascular',\n00221|       'Cardiopulmonary',\n00222|       'Neurological',\n00223|       'Hematological',\n00224|       'Infectious/Malignancy',\n00225|       'Hepatic'\n00226|     ],\n00227|     routineLabs: {\n00228|       title: 'Routine Screening Labs',\n00229|       description: 'Select categories of tests to rule out common explanatory conditions',\n00230|       categories: {\n00231|         basicMetabolic: {\n00232|           title: 'Basic Metabolic',\n00233|           indication: 'Rule out anemia, infection, inflammation, electrolyte abnormalities',\n00234|           tests: ['CBC with differential', 'Comprehensive metabolic panel', 'ESR', 'CRP']\n00235|         },\n00236|         endocrine: {\n00237|           title: 'Endocrine',\n00238|           indication: 'Rule out thyroid dysfunction, diabetes, adrenal insufficiency',\n00239|           tests: ['TSH', 'Free T4', 'HbA1c', 'Cortisol (AM)', 'Vitamin D']\n00240|         },\n00241|         nutritional: {\n00242|           title: 'Nutritional',\n00243|           indication: 'Rule out nutritional deficiencies causing fatigue',\n00244|           tests: ['Vitamin B12', 'Folate', 'Iron studies', 'Ferritin']\n00245|         },\n00246|         autoimmune: {\n00247|           title: 'Autoimmune',\n00248|           indication: 'Screen for autoimmune conditions',\n00249|           tests: ['ANA', 'RF', 'Anti-CCP', 'Celiac antibodies']\n00250|         },\n00251|         cardiac: {\n00252|           title: 'Cardiac',\n00253|           indication: 'Rule out structural heart disease, heart failure',\n00254|           tests: ['ECG', 'Echocardiogram', 'BNP/NT-proBNP']\n00255|         },\n00256|         infectious: {\n00257|           title: 'Infectious',\n00258|           indication: 'Rule out chronic infections',\n00259|           tests: ['Hepatitis B/C', 'HIV', 'Lyme antibodies', 'CMV/EBV antibodies']\n00260|         }\n00261|       }\n00262|     },\n00263|     results: {\n00264|       complete: 'Red-flag Assessment Complete',\n00265|       urgentEval: 'Urgent Evaluation Required',\n00266|       priorityTests: 'Priority Tests (Red Flags)',\n00267|       routineTests: 'Routine Screening Tests',\n00268|       noRedFlags: 'No Red Flags Identified',\n00269|       clinicalSupport: 'Clinical Decision Support',\n00270|       urgent: 'Expedite workup due to high-priority red flags. Consider same-day or next-day evaluation. Hold off on ME/CFS/POTS assessment until red flags ruled out.',\n00271|       priority: 'Complete recommended tests within 1-2 weeks. Can proceed with stand-test if cardiovascular red flags absent. Re-evaluate based on test results.',\n00272|       routine: 'Proceed with routine screening labs. Can continue with ME/CFS/Long COVID/POTS assessment. Consider 4-6 week follow-up for test results.',\n00273|       reassess: 'Reassess',\n00274|       generateRecommendations: 'Generate Recommendations'\n00275|     }\n00276|   },\n00277| \n00278|   standTest: {\n00279|     title: 'Stand-Test Pro',\n00280|     description: 'NASA Lean Stand Test Protocol - 10 minute heart rate monitoring',\n00281|     setup: {\n00282|       title: 'Test Setup',\n00283|       description: 'Choose your preferred method for heart rate monitoring',\n00284|       manual: {\n00285|         title: 'Manual Entry',\n00286|         description: 'Use pulse oximeter, fitness tracker, or manual pulse counting',\n00287|         recommended: 'Recommended'\n00288|       },\n00289|       camera: {\n00290|         title: 'Camera PPG',\n00291|         description: 'Use device camera for photoplethysmography (experimental)',\n00292|         beta: 'Beta Feature'\n00293|       },\n00294|       safety: 'Safety Note: Stop the test immediately if you experience chest pain, severe dizziness, or feel faint. Have a chair nearby for safety.',\n00295|       startTest: 'Start Stand Test'\n00296|     },\n00297|     phases: {\n00298|       baseline: {\n00299|         name: 'Baseline Lying',\n00300|         instructions: 'Lie down comfortably and remain still. Breathe normally and relax.'\n00301|       },\n00302|       standing: {\n00303|         name: 'Standing Phase',\n00304|         instructions: 'Stand up quickly and remain standing. Do not lean against walls or move around.'\n00305|       }\n00306|     },\n00307|     recording: {\n00308|       title: 'Record Heart Rate',\n00309|       description: 'Enter current heart rate reading (record every 1-2 minutes)',\n00310|       baselineHR: 'Baseline HR (lying down)',\n00311|       peakHR: 'Peak Standing HR',\n00312|       systolicBP: 'Systolic BP (optional)',\n00313|       diastolicBP: 'Diastolic BP (optional)',\n00314|       recordReading: 'Record Reading',\n00315|       recentReadings: 'Recent Readings'\n00316|     },\n00317|     results: {\n00318|       title: 'Stand-Test Results',\n00319|       description: 'NASA Lean Stand Test Results - 10 minute protocol',\n00320|       baseline: 'Baseline (Lying)',\n00321|       peakStanding: 'Peak Standing',\n00322|       sustainedStanding: 'Sustained Standing',\n00323|       averageHR: 'Average heart rate',\n00324|       maxHR: 'Maximum heart rate',\n00325|       hrIncrease: 'HR Increase',\n00326|       potsCriteria: 'POTS Criteria',\n00327|       potsMet: 'POTS Criteria Met',\n00328|       potsNotMet: 'POTS Criteria Not Met',\n00329|       interpretation: 'Clinical Interpretation',\n00330|       nextSteps: 'Next Steps',\n00331|       repeatTest: 'Repeat Test'\n00332|     },\n00333|     interpretations: {\n00334|       potsMet: [\n00335|         'Heart rate increase suggests orthostatic intolerance consistent with POTS',\n00336|         'Proceed to POTS subtyping for targeted treatment recommendations',\n00337|         'Consider additional autonomic testing if clinically indicated',\n00338|         'Rule out secondary causes (dehydration, medications, other conditions)'\n00339|       ],\n00340|       potsNotMet: [\n00341|         'Normal orthostatic heart rate response',\n00342|         'POTS unlikely based on current criteria',\n00343|         'Consider other causes of symptoms (ME/CFS, Long COVID without POTS)',\n00344|         'Repeat testing if symptoms persist or worsen'\n00345|       ]\n00346|     },\n00347|     controls: {\n00348|       pause: 'Pause',\n00349|       resume: 'Resume',\n00350|       stop: 'Stop Test'\n00351|     }\n00352|   },\n00353| \n00354|   pem: {\n00355|     title: 'PEM-Quest Assessment',\n00356|     description: 'Post-Exertional Malaise evaluation - 5 validated questions',\n00357|     about: {\n00358|       title: 'About Post-Exertional Malaise (PEM)',\n00359|       description: 'PEM is the worsening of symptoms following physical or mental activity that was previously tolerated. It\\'s a key feature of ME/CFS and often occurs in Long COVID. Symptoms may be delayed and can last days to weeks.'\n00360|     },\n00361|     questions: {\n00362|       frequency: {\n00363|         question: 'How often do you experience a worsening of symptoms following physical activity?',\n00364|         description: 'Consider activities like walking, climbing stairs, or household chores',\n00365|         options: [\n00366|           'Never',\n00367|           'Rarely (less than 25% of the time)',\n00368|           'Sometimes (25-50% of the time)',\n00369|           'Often (50-75% of the time)',\n00370|           'Always or almost always (more than 75% of the time)'\n00371|         ]\n00372|       },\n00373|       mentalFrequency: {\n00374|         question: 'How often do you experience a worsening of symptoms following mental activity?',\n00375|         description: 'Consider activities like reading, concentrating, or problem-solving',\n00376|         options: [\n00377|           'Never',\n00378|           'Rarely (less than 25% of the time)',\n00379|           'Sometimes (25-50% of the time)',\n00380|           'Often (50-75% of the time)',\n00381|           'Always or almost always (more than 75% of the time)'\n00382|         ]\n00383|       },\n00384|       onsetTime: {\n00385|         question: 'How soon after activity do your symptoms typically worsen?',\n00386|         options: [\n00387|           'No worsening occurs',\n00388|           'During the activity',\n00389|           'Immediately after (within 30 minutes)',\n00390|           'Within a few hours (2-6 hours)',\n00391|           'The next day or later'\n00392|         ]\n00393|       },\n00394|       severity: {\n00395|         question: 'How severe is the worsening of your symptoms after activity?',\n00396|         options: [\n00397|           'No worsening',\n00398|           'Mild - slightly worse than before activity',\n00399|           'Moderate - noticeably worse, but manageable',\n00400|           'Severe - significantly worse, difficult to function',\n00401|           'Very severe - unable to function, bedridden'\n00402|         ]\n00403|       },\n00404|       recoveryTime: {\n00405|         question: 'How long does it typically take for your symptoms to return to baseline after activity?',\n00406|         options: [\n00407|           'No recovery time needed',\n00408|           'A few hours',\n00409|           'About one day',\n00410|           'Several days (2-6 days)',\n00411|           'A week or more'\n00412|         ]\n00413|       }\n00414|     },\n00415|     results: {\n00416|       complete: 'PEM Assessment Complete',\n00417|       description: 'Post-Exertional Malaise evaluation based on DePaul criteria',\n00418|       status: 'PEM Status',\n00419|       present: 'Post-Exertional Malaise is likely present',\n00420|       absent: 'Post-Exertional Malaise is unlikely',\n00421|       severityLevels: {\n00422|         none: 'None',\n00423|         mild: 'Mild PEM',\n00424|         moderate: 'Moderate PEM',\n00425|         severe: 'Severe PEM'\n00426|       },\n00427|       clinicalInterpretation: 'Clinical Interpretation',\n00428|       recommendations: {\n00429|         severe: [\n00430|           'Strict activity pacing essential',\n00431|           'Consider disability evaluation',\n00432|           'Specialist ME/CFS clinic referral'\n00433|         ],\n00434|         moderate: [\n00435|           'Implement careful activity pacing',\n00436|           'Monitor for symptom progression',\n00437|           'Consider occupational therapy'\n00438|         ],\n00439|         mild: [\n00440|           'Begin gentle activity pacing',\n00441|           'Education on PEM recognition',\n00442|           'Regular symptom monitoring'\n00443|         ],\n00444|         none: [\n00445|           'PEM not significantly present',\n00446|           'Consider other diagnoses',\n00447|           'Standard activity as tolerated'\n00448|         ]\n00449|       },\n00450|       important: 'Important: PEM is the hallmark symptom of ME/CFS. If present, avoid activities that consistently trigger symptom worsening. Energy management and pacing are key treatment strategies.',\n00451|       retake: 'Retake Assessment'\n00452|     }\n00453|   },\n00454| \n00455|   criteria: {\n00456|     title: 'Criteria Engine',\n00457|     description: 'Apply CDC, NASEM, ESC, WHO diagnostic criteria for final determination',\n00458|     mecfs: {\n00459|       title: 'ME/CFS Criteria (CDC/NASEM 2015)',\n00460|       description: 'Requires substantial fatigue, PEM, unrefreshing sleep, AND either cognitive impairment OR orthostatic intolerance',\n00461|       criteria: [\n00462|         'Substantial reduction or impairment in activity levels that persists for ≥6 months',\n00463|         'Post-exertional malaise (PEM) present',\n00464|         'Unrefreshing sleep',\n00465|         'Cognitive impairment (brain fog)',\n00466|         'Orthostatic intolerance OR autonomic dysfunction'\n00467|       ]\n00468|     },\n00469|     longCovid: {\n00470|       title: 'Long COVID Criteria (WHO/NASEM 2024)',\n00471|       description: 'Post-acute sequelae of SARS-CoV-2 infection with persistent multi-system symptoms',\n00472|       criteria: [\n00473|         'Confirmed or probable SARS-CoV-2 infection',\n00474|         'Symptoms persist ≥3 months from acute illness',\n00475|         'Multi-system symptoms affecting daily functioning',\n00476|         'Symptoms not explained by alternative diagnosis'\n00477|       ],\n00478|       timing: {\n00479|         confirmed: 'Confirmed by test',\n00480|         probable: 'Probable based on symptoms/exposure',\n00481|         suspected: 'Suspected based on timing'\n00482|       }\n00483|     },\n00484|     pots: {\n00485|       title: 'POTS Criteria (ESC 2018/AAS-EFAS 2021)',\n00486|       description: 'Heart rate increase ≥30 bpm within 10 minutes of standing, with symptoms but without orthostatic hypotension',\n00487|       criteria: [\n00488|         'Heart rate increase ≥30 bpm within 10 minutes of standing (≥40 bpm for ages 12-19)',\n00489|         'Sustained heart rate ≥120 bpm while standing OR sustained tachycardia',\n00490|         'Orthostatic symptoms: dizziness, palpitations, fatigue, brain fog, or syncope',\n00491|         'Chronic symptoms present for ≥3 months',\n00492|         'Absence of orthostatic hypotension (SBP drop <20 mmHg or DBP drop <10 mmHg)'\n00493|       ]\n00494|     },\n00495|     results: {\n00496|       complete: 'Diagnostic Criteria Assessment Complete',\n00497|       description: 'Based on CDC, NASEM, ESC, WHO guidelines',\n00498|       diagnosesMet: 'Diagnoses Meeting Criteria',\n00499|       criteriaMet: 'CRITERIA MET',\n00500|       clinicalRecommendations: 'Clinical Recommendations',\n00501|       mecfsManagement: [\n00502|         'Implement activity pacing and energy management',\n00503|         'Avoid graded exercise therapy (GET)',\n00504|         'Consider symptom-directed treatments',\n00505|         'Specialist ME/CFS clinic referral if available'\n00506|       ],\n00507|       longCovidManagement: [\n00508|         'Multidisciplinary approach to symptom management',\n00509|         'Long COVID clinic referral if available',\n00510|         'Monitor for improvement over time',\n00511|         'Address individual symptoms (fatigue, cognitive, respiratory)'\n00512|       ],\n00513|       potsManagement: [\n00514|         'Proceed to subtype determination for targeted therapy',\n00515|         'Non-pharmacological: salt, fluids, compression garments',\n00516|         'Consider cardiology or autonomic specialist referral',\n00517|         'Gradual exercise reconditioning when appropriate'\n00518|       ],\n00519|       reassess: 'Reassess Criteria',\n00520|       downloadReport: 'Download Report',\n00521|       potsSubtype: 'POTS Subtype Analysis'\n00522|     }\n00523|   },\n00524| \n00525|   subtype: {\n00526|     title: 'POTS Subtype & Treatment Advisor',\n00527|     description: 'Determine POTS subtype for personalized treatment recommendations',\n00528|     patientInfo: {\n00529|       title: 'Patient Information',\n00530|       description: 'Basic patient details for treatment planning',\n00531|       comorbidities: 'Relevant Comorbidities (check all that apply)',\n00532|       comorbidityOptions: ['Diabetes', 'Autoimmune Disease', 'EDS', 'MCAS']\n00533|     },\n00534|     subtypes: {\n00535|       hypovolemic: {\n00536|         name: 'Hypovolemic POTS',\n00537|         description: 'Low blood volume causing orthostatic intolerance',\n00538|         criteria: [\n00539|           'Low-normal blood pressure (<110/70)',\n00540|           'Excessive thirst',\n00541|           'Salt craving',\n00542|           'Signs of volume depletion',\n00543|           'Elevated renin/aldosterone (if available)'\n00544|         ],\n00545|         treatments: {\n00546|           nonPharmacological: [\n00547|             'Increase fluid intake to 2.5-3L daily',\n00548|             'Increase sodium intake to 8-10g daily',\n00549|             'Compression garments (30-40 mmHg)',\n00550|             'Gradual exercise reconditioning'\n00551|           ],\n00552|           firstLine: [\n00553|             'Fludrocortisone 0.1-0.2mg daily',\n00554|             'Salt tablets if dietary intake insufficient'\n00555|           ],\n00556|           firstLineMonitoring: [\n00557|             'Monitor serum electrolytes (K+, Na+) every 2-4 weeks initially',\n00558|             'Weekly blood pressure checks (watch for hypertension >140/90)',\n00559|             'Daily weight monitoring for fluid retention',\n00560|             'Monitor for edema, dyspnea, or signs of heart failure',\n00561|             'Contraindications: Active heart failure, severe hypertension, hypokalemia'\n00562|           ],\n00563|           secondLine: [\n00564|             'Desmopressin (DDAVP) for severe cases',\n00565|             'Erythropoietin if anemic'\n00566|           ]\n00567|         }\n00568|       },\n00569|       neuropathic: {\n00570|         name: 'Neuropathic POTS',\n00571|         description: 'Peripheral autonomic neuropathy affecting blood vessel control',\n00572|         criteria: [\n00573|           'Distal small fiber neuropathy symptoms',\n00574|           'GI dysfunction (gastroparesis, constipation)',\n00575|           'Anhidrosis or reduced sweating',\n00576|           'Pupillary abnormalities',\n00577|           'History of diabetes or autoimmune disease'\n00578|         ],\n00579|         treatments: {\n00580|           nonPharmacological: [\n00581|             'Compression garments',\n00582|             'Leg elevation',\n00583|             'Avoid heat exposure',\n00584|             'Small frequent meals'\n00585|           ],\n00586|           firstLine: [\n00587|             'Midodrine 2.5-10mg TID',\n00588|             'Pyridostigmine 30-60mg TID'\n00589|           ],\n00590|           firstLineMonitoring: [\n00591|             'Monitor supine blood pressure (risk of supine hypertension)',\n00592|             'Take last dose 4+ hours before bedtime',\n00593|             'Monitor for urinary retention, especially in men',\n00594|             'Watch for scalp tingling, goosebumps (dose-related effects)',\n00595|             'Contraindications: Severe heart disease, urinary retention, pheochromocytoma'\n00596|           ],\n00597|           secondLine: [\n00598|             'Droxidopa (if available)',\n00599|             'Alpha-lipoic acid for neuropathy',\n00600|             'IVIG for autoimmune cases'\n00601|           ]\n00602|         }\n00603|       },\n00604|       hyperadrenergic: {\n00605|         name: 'Hyperadrenergic POTS',\n00606|         description: 'Excessive sympathetic nervous system activation',\n00607|         criteria: [\n00608|           'Hypertension when standing',\n00609|           'Anxiety, panic attacks, tremor',\n00610|           'Migraine headaches',\n00611|           'Cold hands and feet',\n00612|           'Elevated standing norepinephrine >600 pg/mL'\n00613|         ],\n00614|         treatments: {\n00615|           nonPharmacological: [\n00616|             'Stress reduction techniques',\n00617|             'Avoid stimulants (caffeine)',\n00618|             'Regular sleep schedule',\n00619|             'Gentle exercise'\n00620|           ],\n00621|           firstLine: [\n00622|             'Propranolol 10-20mg BID-QID',\n00623|             'Clonidine 0.1-0.2mg BID'\n00624|           ],\n00625|           firstLineMonitoring: [\n00626|             'Monitor heart rate (target: reduce by 10-20 bpm)',\n00627|             'Blood pressure monitoring (watch for hypotension)',\n00628|             'Screen for asthma/COPD before starting beta-blockers',\n00629|             'Monitor for fatigue, depression, or exercise intolerance',\n00630|             'Contraindications: Asthma, severe heart failure, heart block'\n00631|           ],\n00632|           secondLine: [\n00633|             'Ivabradine 2.5-7.5mg BID',\n00634|             'Methyldopa',\n00635|             'Labetalol for hypertension'\n00636|           ],\n00637|           secondLineMonitoring: [\n00638|             'Ivabradine: ECG monitoring, target HR 60-70 bpm',\n00639|             'Monitor for visual disturbances (phosphenes) with ivabradine',\n00640|             'Avoid ivabradine with strong CYP3A4 inhibitors',\n00641|             'Regular cardiac rhythm assessment'\n00642|           ]\n00643|         }\n00644|       },\n00645|       autoimmune: {\n00646|         name: 'Autoimmune POTS',\n00647|         description: 'Autoimmune-mediated autonomic dysfunction',\n00648|         criteria: [\n00649|           'Personal/family history of autoimmune disease',\n00650|           'Rapid onset of symptoms',\n00651|           'Viral illness trigger (EBV, COVID, etc.)',\n00652|           'Positive autonomic antibodies (if tested)',\n00653|           'Other autoimmune markers positive'\n00654|         ],\n00655|         treatments: {\n00656|           nonPharmacological: [\n00657|             'Standard POTS measures',\n00658|             'Avoid infection triggers',\n00659|             'Stress management',\n00660|             'Anti-inflammatory diet'\n00661|           ],\n00662|           firstLine: [\n00663|             'Standard POTS medications',\n00664|             'Trial of corticosteroids'\n00665|           ],\n00666|           firstLineMonitoring: [\n00667|             'Monitor blood glucose (steroid-induced diabetes risk)',\n00668|             'Watch for mood changes, insomnia with steroids',\n00669|             'Bone density monitoring with long-term steroid use',\n00670|             'Monitor for signs of infection (immunosuppression)',\n00671|             'Regular complete blood count and metabolic panel'\n00672|           ],\n00673|           secondLine: [\n00674|             'IVIG therapy',\n00675|             'Immunosuppressive agents',\n00676|             'Plasmapheresis for severe cases'\n00677|           ],\n00678|           secondLineMonitoring: [\n00679|             'IVIG: Pre-medication for allergic reactions, monitor renal function',\n00680|             'Immunosuppressants: Regular CBC, liver function, infection screening',\n00681|             'Plasmapheresis: Coagulation monitoring, electrolyte replacement',\n00682|             'Monitor for opportunistic infections with immunotherapy'\n00683|           ]\n00684|         }\n00685|       }\n00686|     },\n00687|     results: {\n00688|       complete: 'POTS Subtype Analysis Complete',\n00689|       description: 'Personalized treatment recommendations based on subtype assessment',\n00690|       primary: 'Primary',\n00691|       likelihood: 'likelihood',\n00692|       criteriaMetTitle: 'Criteria Met',\n00693|       allSubtypeScores: 'All Subtype Scores',\n00694|       nonPharmacological: 'Non-Pharmacological',\n00695|       firstLineRx: 'First-Line Rx',\n00696|       secondLineOptions: 'Second-Line Options',\n00697|       mixedSubtype: 'Mixed Subtype Considerations: This patient also shows features of multiple subtypes. Consider combination therapy approaches and monitor response to initial treatment.',\n00698|       clinicalPearls: 'Clinical Pearls',\n00699|       pearls: [\n00700|         'Start with non-pharmacological interventions for all POTS subtypes',\n00701|         'Begin medications at low doses and titrate slowly',\n00702|         'Monitor response and adjust treatment based on symptom improvement',\n00703|         'Consider specialist referral for complex cases or treatment failures',\n00704|         'Re-assess subtype if treatment response is poor'\n00705|       ],\n00706|       reassess: 'Reassess Subtype',\n00707|       downloadPlan: 'Download Treatment Plan',\n00708|       analysisHeader: 'SUBTYPE ANALYSIS',\n00709|       secondaryConsiderations: 'Secondary considerations',\n00710|       and: ' and '\n00711|     }\n00712|   },\n00713| \n00714|   newPatient: {\n00715|     title: 'New Patient Assessment',\n00716|     description: 'Intelligent guided evaluation for ME/CFS, Long COVID, and POTS',\n00717|     demographics: {\n00718|       title: 'Patient Information',\n00719|       description: 'Basic demographics for clinical documentation',\n00720|       step: 'Step 1 of 7: Patient Demographics',\n00721|       age: 'Patient Age',\n00722|       gender: 'Gender',\n00723|       clinicianName: 'Clinician Name',\n00724|       patientId: 'Patient ID/MRN',\n00725|     startAssessment: 'Start Assessment'\n00726|     },\n00727|     progress: {\n00728|       step1: 'Demographics',\n00729|       step2: 'Quick Screen',\n00730|       step3: 'Red Flags',\n00731|       step4: 'Stand Test',\n00732|       step5: 'PEM Quest',\n00733|       step6: 'Criteria',\n00734|       step7: 'Summary'\n00735|     },\n00736|     redFlags: {\n00737|       title: 'Red Flag Assessment',\n00738|       description: 'Check for symptoms requiring urgent evaluation',\n00739|       selectSymptoms: 'Select any symptoms present',\n00740|       continueAssessment: 'Continue Assessment'\n00741|     },\n00742|     standTest: {\n00743|       title: 'Orthostatic Assessment',\n00744|       description: 'Record baseline and standing heart rates',\n00745|       measurements: 'Heart Rate Measurements',\n00746|       measurementDescription: 'Enter heart rate after 5 minutes lying down and peak heart rate within 10 minutes of standing',\n00747|       baselineHR: 'Baseline HR (lying down)',\n00748|       peakHR: 'Peak Standing HR',\n00749|       hrIncrease: 'HR Increase',\n00750|       potsCriteria: 'POTS Criteria (≥30 bpm)',\n00751|       continueToPEM: 'Continue to PEM Assessment'\n00752|     },\n00753|     pemAssessment: {\n00754|       title: 'PEM Assessment',\n00755|       description: 'Post-Exertional Malaise evaluation',\n00756|       finalizeAssessment: 'Finalize Assessment'\n00757|     },\n00758|     processing: {\n00759|       title: 'Processing Diagnostic Criteria...',\n00760|       description: 'Analyzing responses against CDC, NASEM, ESC, and WHO guidelines'\n00761|     },\n00762|     results: {\n00763|       title: 'Patient Assessment Complete',\n00764|       description: 'Comprehensive clinical evaluation with SOAP documentation',\n00765|       primary: 'Primary',\n00766|       noDefinitiveDiagnoses: 'No Definitive Diagnoses: Consider alternative diagnoses, subclinical presentations, or ongoing symptom monitoring. Some patients may benefit from symptomatic treatment while monitoring for progression.',\n00767|       keyResults: 'Key Assessment Results',\n00768|       riskLevel: 'Risk Level',\n00769|       screeningScore: 'Screening Score',\n00770|       pemPresent: 'PEM Present',\n00771|       potsCriteria: 'POTS Criteria',\n00772|       redFlags: 'Red Flags',\n00773|       priority: 'Priority',\n00774|       newAssessment: 'New Assessment',\n00775|       downloadSOAP: 'Download SOAP Note'\n00776|     }\n00777|   },\n00778| \n00779|   conditions: {\n00780|     mecfs: {\n00781|       name: 'ME/CFS',\n00782|       fullName: 'Myalgic Encephalomyelitis/Chronic Fatigue Syndrome',\n00783|       icdCode: 'G93.32',\n00784|       criteria: [\n00785|         'Substantial fatigue not relieved by rest',\n00786|         'Post-exertional malaise',\n00787|         'Unrefreshing sleep',\n00788|         'Cognitive impairment or orthostatic intolerance'\n00789|       ]\n00790|     },\n00791|     longCovid: {\n00792|       name: 'Long COVID',\n00793|       fullName: 'Post-acute sequelae of SARS-CoV-2',\n00794|       icdCode: 'U09.9',\n00795|       criteria: [\n00796|         'COVID-19 infection history',\n00797|         'Symptoms ≥3 months duration',\n00798|         'Multi-system involvement',\n00799|         'Functional impairment'\n00800|       ]\n00801|     },\n00802|     pots: {\n00803|       name: 'POTS',\n00804|       fullName: 'Postural Orthostatic Tachycardia Syndrome',\n00805|       icdCode: 'I47.1',\n00806|       criteria: [\n00807|         'HR increase ≥30 bpm on standing (≥40 for age 12-19)',\n00808|         'Orthostatic symptoms (dizziness, palpitations, fatigue)',\n00809|         'Chronic duration ≥3 months',\n00810|         'No orthostatic hypotension (SBP <20mmHg, DBP <10mmHg drop)'\n00811|       ]\n00812|     }\n00813|   },\n00814| \n00815|   navigation: {\n00816|     assessmentModules: 'Assessment Modules',\n00817|     guidelines: 'Guidelines',\n00818|     diagnosticTools: 'Educational Tools',\n00819|     clinicalGuidelines: 'Clinical Guidelines & References',\n00820|     guidelinesDescription: 'Evidence-based guidelines used in InvisibleDx educational modules',\n00821|     assessmentModulesSection: 'Assessment Modules',\n00822|     guidelinesSection: 'Guidelines & References',\n00823|     moreGuidelines: 'more guidelines',\n00824|     smartBadge: 'Smart'\n00825|   },\n00826| \n00827|   languages: {\n00828|     en: 'English',\n00829|     nl: 'Nederlands',\n00830|     da: 'Dansk'\n00831|   },\n00832| \n00833|   disclaimer: 'EDUCATIONAL TOOL ONLY - This open-source educational tool is designed for healthcare education and learning purposes only. It is NOT a medical device and must NOT be used for patient care, diagnosis, or treatment decisions. Always consult qualified medical professionals for patient care.',\n00834| \n00835|   footer: {\n00836|     about: {\n00837|       title: 'About InvisibleDx',\n00838|       description: 'InvisibleDx is an open-source educational tool for learning about ME/CFS, Long COVID, and POTS criteria. Designed exclusively for healthcare education and research purposes - NOT for patient care or medical use.',\n00839|       badges: {\n00840|         sensitivity: '94% Sensitivity',\n00841|         evidenceBased: 'Evidence-Based',\n00842|         openSource: 'Open Source'\n00843|       }\n00844|     },\n00845|     creator: {\n00846|       title: 'Creator & License',\n00847|       createdBy: 'Created by:',\n00848|       name: 'Willem Gielen MD',\n00849|       organization: 'Nordjysk Speciallaegeklinik',\n00850|       license: 'Open source under MIT License',\n00851|       linkedinProfile: 'LinkedIn Profile',\n00852|       organizationWebsite: 'Organization Website',\n00853|       githubRepository: 'GitHub Repository'\n00854|     },\n00855|     evidence: {\n00856|       title: 'Evidence Base',\n00857|       guidelines: [\n00858|         {\n00859|           title: 'ME/CFS Basics - CDC (2024)',\n00860|           url: 'https://www.cdc.gov/me-cfs/about/'\n00861|         },\n00862|         {\n00863|           title: 'NASEM ME/CFS Report (2015)',\n00864|           url: 'https://nap.nationalacademies.org/read/19012'\n00865|         },\n00866|         {\n00867|           title: 'D-A-CH ME/CFS Consensus (2024)',\n00868|           url: 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11093804/'\n00869|         },\n00870|         {\n00871|           title: 'WHO Long COVID Definition (2021)',\n00872|           url: 'https://www.who.int/publications/i/item/9789240025035'\n00873|         },\n00874|         {\n00875|           title: 'ESC POTS Guidelines (2018)',\n00876|           url: 'https://academic.oup.com/europace/article/20/6/921/4824690'\n00877|         },\n00878|         {\n00879|           title: 'AAS/EFAS POTS Consensus (2021)',\n00880|           url: 'https://link.springer.com/article/10.1007/s10286-021-00822-5'\n00881|         },\n00882|         {\n00883|           title: 'NASA Lean Stand Test Protocol',\n00884|           url: 'https://ntrs.nasa.gov/citations/20150021566'\n00885|         }\n00886|       ]\n00887|     },\n00888|     notes: {\n00889|       title: 'Important Notes',\n00890|       items: [\n00891|         'Training tool only - NOT for patient care',\n00892|         'Educational simulation - NOT real diagnosis',\n00893|         'Open-source software for learning purposes',\n00894|         'Must NOT replace medical professional judgment',\n00895|         'For healthcare education and research only',\n00896|         'Contact medical professionals for patient care'\n00897|       ]\n00898|     },\n00899|     bottom: {\n00900|       version: 'InvisibleDx v1.0 - Educational Tool',\n00901|       copyright: '© 2025 Willem Gielen MD - MIT License',\n00902|       audienceLabel: 'For Healthcare Education Only',\n00903|       badge: 'Research & Education Use'\n00904|     },\n00905|     technical: 'Educational simulation based on peer-reviewed literature. Training data for educational purposes only. This tool is NOT validated for clinical use and must NOT be used for patient care or medical decisions.'\n00906|   },\n00907| \n00908|   ppgCamera: {\n00909|     title: 'Camera PPG Heart Rate',\n00910|     description: 'Place your fingertip gently over the camera lens with flashlight on',\n00911|     fingerDetected: 'Finger Detected',\n00912|     placeFingerPrompt: 'Place Finger',\n00913|     signalQuality: {\n00914|       poor: 'poor',\n00915|       fair: 'fair',\n00916|       good: 'good'\n00917|     },\n00918|     status: {\n00919|       stopped: 'stopped',\n00920|       starting: 'starting',\n00921|       detecting: 'detecting',\n00922|       measuring: 'measuring'\n00923|     },\n00924|     recordReading: 'Record Reading',\n00925|     instructions: {\n00926|       flashlight: 'Turn on your device\\'s flashlight',\n00927|       placement: 'Gently place fingertip over camera lens',\n00928|       stillness: 'Stay still and breathe normally',\n00929|       wait: 'Wait for stable reading (10+ seconds)'\n00930|     },\n00931|     errors: {\n00932|       cameraAccess: 'Camera access denied',\n00933|       noCamera: 'No camera available'\n00934|     }\n00935|   },\n00936| \n00937|   soapNotes: {\n00938|     clinician: 'Clinician',\n00939|     patientId: 'Patient ID',\n00940|     age: 'Age',\n00941|     gender: 'Gender',\n00942|     notSpecified: 'Not specified',\n00943|     notRecorded: 'Not recorded',\n00944|     pemPresent: 'Present',\n00945|     notPresent: 'Not present',\n00946|     baselineHR: 'Baseline HR',\n00947|     peakStandingHR: 'Peak Standing HR',\n00948|     hrIncrease: 'HR Increase',\n00949|     cannotCalculate: 'Cannot calculate',\n00950|     potsCriteriaMet: 'MET (≥30 bpm increase)',\n00951|     potsNotMet: 'Not met',\n00952|     severity: 'severity'\n00953|   }\n00954| }\n</file>",
    "metadata": {
      "preview": "import { Translation } from './types'\n\nexport const en: Translation = {\n  app: {\n    title: 'InvisibleDx: ME/CFS · Long COVID · POTS',\n    subtitle: 'An educational tool for learning evidence-based criteria for ME/CFS, Long COVID, and POTS. For healthcare education and research purposes only.',\n    tagline: 'Making invisible diseases visible - with evidence, empathy and code.',\n    backToDashboard: 'Back to Dashboard'\n  },\n\n  common: {\n    yes: 'Yes',\n    no: 'No',\n    next: 'Next',\n    previous: 'Previous',\n    continue: 'Continue',\n    complete: 'Complete',\n    cancel: 'Cancel',\n    save: 'Save',\n    download: 'Download',"
    },
    "title": "lib/translations/en.ts",
    "time": {
      "start": 1758393754295,
      "end": 1758393754300
    }
  }
}